Mumbai, 8th June 2026: FUJIFILM India, a leader in advanced diagnostic imaging solutions, today announced the installation of its latest AI Powered Digital Mammography System, AMULET SOPHINITY at NM Medical. The announcement was made during an installation event at NM Medical; a leading diagnostic healthcare provider with 22+ centres and a multidisciplinary team of more than 1000 professionals and over 30 years of experience. Reinforcing the continued commitment towards strengthening preventive healthcare infrastructure and enabling early breast cancer detection through advanced imaging innovation.
India’s healthcare ecosystem is witnessing a growing emphasis on preventive healthcare and early disease detection, particularly in women’s health. According to estimates from the Indian Council of Medical Research, National Cancer Registry Programme Breast cancer is projected to remain the leading cancer among women in India, with over 2.32 lakh cases estimated in 2025. As timely screening continues to play a critical role in enabling early diagnosis and improving clinical outcomes, rising awareness, expanding access to diagnostic services, and increasing adoption of advanced imaging technologies are further accelerating the need for clinically reliable, patient-friendly, and workflow-efficient mammography solutions across healthcare institutions in the country.
Designed with a strong focus on patient comfort, diagnostic precision, and workflow efficiency, AMULET SOPHINITY represents Fujifilm’s next-generation mammography platform built around the philosophy of “Sophisticated Features. Human Comfort.” The system integrates advanced AI-enabled technologies, high-definition imaging capabilities, and ergonomically designed patient-centric features to support radiologists and technologists in delivering accurate, efficient, and comfortable breast imaging experiences.
At the core of AMULET SOPHINITY is Fujifilm’s advanced detector technology, featuring a 50 μm direct conversion detector with a unique hexagonal pixel structure that enables high-definition imaging while supporting low-dose screening. The platform also offers tomosynthesis imaging in both Standard (ST) and High-Resolution (HR) modes to support improved lesion visibility and diagnostic confidence. Additional features such as S-View synthesized 2D imaging and optional Contrast Enhanced Digital Mammography (CEDM) enhance its clinical capabilities.
The system has been specifically designed to improve patient experience during mammography procedures. Compared to conventional models, AMULET SOPHINITY features a significantly thinner and curved-edge detector design that reduces abdominal pressure during positioning and supports improved comfort for wheelchair users and women across varying body types. The platform also incorporates Comfort Comp automatic decompression technology, which intelligently reduces compression pressure after optimal positioning while maintaining image quality, helping minimize patient discomfort during screening.
Further strengthening workflow efficiency and positioning accuracy, the system integrates Fujifilm’s REiLI Medical AI technologies, including Intelligent AEC for optimized dose management based on breast composition, Positioning MAP for reproducible positioning support, and AI-driven Positioning Analysis tools that assist technologists in continuously improving imaging quality and consistency.
The AMULET SOPHINITY platform also features a compact, space-saving footprint through integrated system architecture, enabling easier deployment across high-throughput hospitals, diagnostic centres, and space-constrained imaging environments. Its streamlined workflow design, user-friendly operation console, and rapid quality control tools further support operational efficiency and reliable clinical performance.
Commenting on the 1st installation in India, Mr. Koji Wada, Managing Director, FUJIFILM India, said, “India is emerging as one of the world’s fastest-growing healthcare markets, with rising demand for advanced diagnostic technologies across clinical specialties. At Fujifilm, we continue to work towards bringing diverse ideas, unique capabilities, and extraordinary people together to change the world. The first-of-its-kind installation of AMULET SOPHINITY in India at NM Medical reflects this commitment and is guided by our Group Purpose of ‘Giving our world more smiles.’ We remain committed to bringing Japanese precision and advanced healthcare technologies to the Indian healthcare ecosystem in ways that support early diagnosis, greater accessibility, and better healthcare outcomes across the country.”
Dr. Nilesh Shah, Chairman, NM Medical, said, At NM Medical, our focus has always been on strengthening access to advanced, reliable, and patient-centric diagnostic solutions. In breast imaging, technology plays an important role in enabling timely detection, improving diagnostic confidence, and making the screening experience more comfortable for patients. With this addition of AI powered digital mammography combined with biopsies, histopathology, and genomics, we aim to further enhance women’s healthcare services through precision-led imaging and a continued commitment to early diagnosis.”
“In breast imaging, clarity, positioning accuracy, dose optimization, and patient comfort are all equally important. Advanced digital mammography and tomosynthesis technologies can support radiologists with better visualization, especially in cases where breast tissue overlap may make interpretation more challenging. AI-assisted positioning and comfort-focused design features also help improve consistency during imaging while making the screening experience more patient-friendly”, stated Dr. Shilpa Lad, Consultant Breast Imaging and Interventions, NM Medical at the launch.
Through this installation at NM Medical, FUJIFILM India further strengthens its position as a trusted healthcare technology partner in India’s diagnostic imaging ecosystem. The company continues to focus on advancing AI-enabled imaging technologies, workflow automation, preventive healthcare, and clinician-focused innovation to support timely diagnosis, improved patient outcomes, and the evolving needs of healthcare providers across the country.
About FUJIFILM India:
FUJIFILM India Pvt. Ltd. is a subsidiary of FUJIFILM Corporation, Japan. Established in 2007, FUJIFILM India is present in four business segments – Healthcare, Electronics, Business Innovation and Imaging. With a vast portfolio of technologically advanced products, the company is involved in the business of Healthcare, Endoscopy Systems, Photo Imaging Solutions, Electronic Imaging, instax™ (Instant Photo System), Optical Devices, Graphic Communication Solutions, Multifunction Printers, Recording Media, Industrial Products and Electronic Materials.
For more information please visit: https://www.fujifilm.com/in/en
About NM Medical:
NM Medical is one of India’s leading diagnostic healthcare providers and a pioneer in preventive healthcare and advanced diagnostics. Established in 1980, NM Medical offers comprehensive pathology, radiology, molecular diagnostics, cardiology, genetic testing, and preventive health check-up services under one roof. With a network of centers across Mumbai, Pune, Bengaluru, Nashik, Navi Mumbai, and Thane, the organization serves patients through state-of-the-art diagnostic infrastructure, advanced imaging technologies, and a team of experienced healthcare professionals.
Known for its commitment to diagnostic excellence, NM Medical has been at the forefront of introducing advanced technologies such as Digital PET-CT, AI-powered 3T MRI, digital histopathology, molecular pathology, and specialized breast screening services. With over 30 years of experience, 22+ centers, and a multidisciplinary team of more than 1,000 professionals, NM Medical continues to be a trusted partner for clinicians and patients in India and internationally, delivering accurate, timely, and patient-centric diagnostic solutions
